Axe Compute's stock surges nearly 590% after rebranding to AI infrastructure provider
In late 2025, Predictive Oncology transformed into Axe Compute and began trading on the Nasdaq under the ticker AGPU. The company shifted from cancer research to offering GPU-based computing power for AI development. This strategic pivot has led to a nearly 590% increase in its stock price over six months as of September 2026, with shares reaching around $11. Axe Compute leverages the Aethir distributed network and offers customizable solutions that allow clients to choose their hardware, location, and contract terms. CEO Chris Miglino highlighted a growing order book, citing $3 billion in closed business and an additional $6 billion pipeline. President Kyle Okamoto noted approximately $696 million in annual recurring revenue from announced contracts. Despite the stock's significant rise, Axe Compute reported minimal computing segment revenue for fiscal year 2025 with a net loss of $233.1 million. The company is currently valued at around $128 million and remains speculative as it builds its infrastructure based on pre-paid customer commitments.
Tickers: $POAI
Topics: AI GPU Computing Rebranding Stock Performance